StreetInsider.com News Articles

Form 6-K CollPlant Biotechnologie For: Oct 15

Thu, 15 Oct 2026 06:07:00 -0400

si-local-file:///var/storage/secattach/20261015/27189091.html

Form 6-K CollPlant Biotechnologie For: Oct 09

Fri, 09 Oct 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20261009/27172290.html

CollPlant raises $3.7M in private placement to fund LightSolver unit

Fri, 09 Oct 2026 09:00:50 -0400

CollPlant Biotechnologies (Nasdaq: CLGN) announced it has entered into definitive agreements for a private placement expected to raise approximately $3.7 million in gross proceeds, before placement agent fees and related expenses.

The offering includes 989,301 ordinary shares, or ordinary share equivalents, priced at $3.74 per share, along with unregistered warrants to purchase up to 1,483,952 ordinary shares at an exercise price of $3.74 per share. The warrants are exercisable immediately upon issuance and expire five years after the effective date of a registration statement covering the shares underlying the warrants.

The private placement is comprised primarily of existing investors and is expected

COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENT

Fri, 09 Oct 2026 09:00:00 -0400

Transaction Led Primarily by Existing Investors to Accelerate LightSolver's Laser-Based Supercomputing Development

REHOVOT, Israel, Oct. 9, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), an innovative technology company operating at the intersection of deep-tech photonic computing and biotechnology today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 989,301 of the Company's

COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENT

Fri, 09 Oct 2026 09:00:00 -0400

Transaction Led Primarily by Existing Investors to Accelerate LightSolver's Laser-Based Supercomputing Development

Form SCHEDULE 13G CollPlant Biotechnologie Filed by: Sagy Ami

Thu, 08 Oct 2026 10:56:00 -0400

si-local-file:///var/storage/secattach/20261008/27165500.html

Form SCHEDULE 13D/A CollPlant Biotechnologie Filed by: Sagy Ami

Thu, 08 Oct 2026 10:54:00 -0400

si-local-file:///var/storage/secattach/20261008/27165493.html

Form 6-K CollPlant Biotechnologie For: Oct 06

Tue, 06 Oct 2026 08:06:00 -0400

si-local-file:///var/storage/secattach/20261006/27152299.html

LightSolver files patent for photonic computing simulation expansion

Tue, 06 Oct 2026 07:02:50 -0400

CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) announced that its subsidiary, LightSolver, has filed a provisional patent application with the U.S. Patent and Trademark Office for an invention designed to expand the capabilities of its all-optical, laser-based computing platform.

The application, titled "Configuring a Programmable Analog Processor to Solve Inhomogeneous Boundary Value Problems," describes a method for solving complex physical and engineering problems. Specifically, the invention targets partial differential equations underlying heat transfer, diffusion, electrostatics, and fluid-flow phenomena, including those with complex geometries and boundary conditions.

A key element of the invention allows boundary conditions and other problem parameters to be incorporated directly into

LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations

Tue, 06 Oct 2026 07:00:00 -0400

CollPlant Advances its Photonic Computing Strategy Through LightSolver's Growing IP Portfolio

REHOVOT, Israel, Oct. 6, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its subsidiary, LightSolver, has filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for an invention that significantly expands the capabilities of its all-optical,

LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations

Tue, 06 Oct 2026 07:00:00 -0400

CollPlant Advances its Photonic Computing Strategy Through LightSolver's Growing IP Portfolio

CollPlant (CLGN) Misses Q2 EPS by 165c

Thu, 01 Oct 2026 07:04:34 -0400

CollPlant (NASDAQ: CLGN) reported Q2 EPS of ($1.89), $1.65 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $110 thousand versus the consensus estimate of $480 thousand.

For earnings history and earnings-related data on CollPlant (CLGN) click here.

Form 6-K CollPlant Biotechnologie For: Jun 30

Wed, 30 Sep 2026 17:27:00 -0400

si-local-file:///var/storage/secattach/20260930/27129644.html

COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Wed, 30 Sep 2026 17:20:00 -0400

Strategic Expansion into Photonic Computing via LightSolver Acquisition Diversifies Technology Portfolio Alongside Continued Innovations in Regenerative Medicine

REHOVOT, Israel, Sept. 30, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), today announced financial results for the second quarter of 2026 and provided a corporate update.

COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Wed, 30 Sep 2026 17:20:00 -0400

Strategic Expansion into Photonic Computing via LightSolver Acquisition Diversifies Technology Portfolio Alongside Continued Innovations in Regenerative Medicine

REHOVOT, Israel, Sept. 30, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), today announced financial results for the second quarter of 2026 and provided a corporate update.

Form 6-K CollPlant Biotechnologie For: Sep 24

Thu, 24 Sep 2026 14:10:00 -0400

si-local-file:///var/storage/secattach/20260924/27101467.html

LightSolver and HLRS publish photonic computing study in ACM journal

Thu, 24 Sep 2026 08:01:16 -0400

CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) announced the publication of a peer-reviewed study conducted by its subsidiary LightSolver Ltd. and the High-Performance Computing Center Stuttgart (HLRS), examining the performance of photonic computing architecture for high-performance computing (HPC) workloads.

The paper, titled "Accelerating Sparse Linear Solvers with an Optical Laser Processing Unit," was published in the proceedings of the 23rd ACM International Conference on Computing Frontiers. The study benchmarked projected performance of LightSolver's Laser Processing Unit (LPU) architecture — evaluated using an emulator rather than physical hardware — against state-of-the-art iterative algorithms running on a GPU.

Across the benchmark problems tested, the study projected

LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads

Thu, 24 Sep 2026 08:00:00 -0400

Peer-reviewed study published by ACM: LightSolver's LPU architecture demonstrated significantly lower projected time-to-solution, compared to state-of-the-art algorithms running on a GPU

REHOVOT, Israel, September 24, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced the publication of joint research conducted by its subsidiary LightSolver Ltd. ("LightSolver"), a pioneer of pure

LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads

Thu, 24 Sep 2026 08:00:00 -0400

Peer-reviewed study published by ACM: LightSolver's LPU architecture demonstrated significantly lower projected time-to-solution, compared to state-of-the-art algorithms running on a GPU

Form 6-K CollPlant Biotechnologie For: Sep 22

Tue, 22 Sep 2026 10:41:00 -0400

si-local-file:///var/storage/secattach/20260922/27089457.html

CollPlant regains Nasdaq compliance after minimum bid price issue

Tue, 22 Sep 2026 07:30:25 -0400

CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) announced it has received formal notification from Nasdaq confirming the company has regained compliance with Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share.

Nasdaq determined that CollPlant's ordinary shares maintained a closing bid price at or above $1.00 for ten consecutive business days, from Sept. 4 to Sept. 18, 2026. Nasdaq has formally closed the compliance matter.

The compliance issue originated from a deficiency notice issued March 23, 2026, after CollPlant's shares traded below the $1.00 minimum bid price threshold for 30 consecutive business days.

"Maintaining our Nasdaq listing is of paramount importance

CollPlant Regains Compliance with Nasdaq Minimum Bid Price Requirement

Tue, 22 Sep 2026 07:30:00 -0400

Nasdaq confirms the Company satisfies continued listing criteria under Listing Rule 5550(a)(2), officially closing the compliance matter

Follows the recent completion of the LightSolver acquisition, marking CollPlant's strategic expansion into high-performance computing (HPC) and photonics

REHOVOT, Israel, Sept. 22, 2026 /PRNewswire/ --

CollPlant Regains Compliance with Nasdaq Minimum Bid Price Requirement

Tue, 22 Sep 2026 07:30:00 -0400

Nasdaq confirms the Company satisfies continued listing criteria under Listing Rule 5550(a)(2), officially closing the compliance matter

Follows the recent completion of the LightSolver acquisition, marking CollPlant's strategic expansion into high-performance computing (HPC) and photonics

REHOVOT, Israel, Sept. 22, 2026 /PRNewswire/ --

Form 6-K CollPlant Biotechnologie For: Sep 18

Fri, 18 Sep 2026 08:31:00 -0400

si-local-file:///var/storage/secattach/20260918/27078517.html

CollPlant to Host LightSolver Investor Webinar on September 17, 2026

Thu, 10 Sep 2026 07:00:00 -0400

REHOVOT, Israel, Sept. 10, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its subsidiary LightSolver Ltd. ("LightSolver"), a pioneer of pure photonic computing with the world's first Laser Processing Unit™ (LPU™), a fundamentally new computing architecture that uses light itself to compute, will host an investor webinar on Thursday, September 17, 2026, at 8:30 a.m. Eastern Time.